Homo sapiens Raw sequence reads
This study will allow for collection of research specimens from patients receiving standard of care targeted cancer cell therapy at UMGCCC as well as those participating in UMGCCC clinical trials that involve targeted cancer cell therapies. Patients who may have received cancer cell therapies at outside institutions and subsequently transfer care to UMGCCC may also participate. These research specimens will allow University researchers to investigate and understand the biology of these novel therapies.